6.
Zhu Z, Xu T, Guo D, HuangFu X, Zhong C, Yang J
. Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke. Stroke. 2018; 49(2):377-383.
PMC: 5780195.
DOI: 10.1161/STROKEAHA.117.019476.
View
7.
Sowa K, Nito C, Nakajima M, Suda S, Nishiyama Y, Sakamoto Y
. Impact of Dental Pulp Stem Cells Overexpressing Hepatocyte Growth Factor after Cerebral Ischemia/Reperfusion in Rats. Mol Ther Methods Clin Dev. 2018; 10:281-290.
PMC: 6108066.
DOI: 10.1016/j.omtm.2018.07.009.
View
8.
Qin C, Yang S, Chu Y, Zhang H, Pang X, Chen L
. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022; 7(1):215.
PMC: 9259607.
DOI: 10.1038/s41392-022-01064-1.
View
9.
Bustamante A, Garcia-Berrocoso T, Rodriguez N, Llombart V, Ribo M, Molina C
. Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care. Eur J Intern Med. 2016; 29:9-21.
DOI: 10.1016/j.ejim.2015.11.030.
View
10.
Boers A, Jansen I, Beenen L, Devlin T, San Roman L, Heo J
. Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trials. J Neurointerv Surg. 2018; 10(12):1137-1142.
DOI: 10.1136/neurintsurg-2017-013724.
View
11.
Tsiantoulas D, Eslami M, Obermayer G, Clement M, Smeets D, Mayer F
. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans. Nature. 2021; 597(7874):92-96.
DOI: 10.1038/s41586-021-03818-3.
View
12.
Scherer H, Haupl T, Burmester G
. The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110:102400.
DOI: 10.1016/j.jaut.2019.102400.
View
13.
Zhao L, Berra H, Duan W, Singhal S, Mehta J, Apkarian A
. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke. 2007; 38(10):2804-11.
DOI: 10.1161/STROKEAHA.107.486217.
View
14.
Li F, Liu P, Huang Y, Li L, Zhang S, Yang Z
. The Incremental Prognostic Value of Hepatocyte Growth Factor in First-Ever Acute Ischemic Stroke: An Early Link Between Growth Factor and Interleukins. Front Neurol. 2021; 12:691886.
PMC: 8371202.
DOI: 10.3389/fneur.2021.691886.
View
15.
Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J
. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension. 2004; 44(2):203-9.
DOI: 10.1161/01.HYP.0000136394.08900.ed.
View
16.
Yeo S, Barratt J
. The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy. Clin Kidney J. 2023; 16(Suppl 2):ii9-ii18.
PMC: 10695512.
DOI: 10.1093/ckj/sfad200.
View
17.
Gu H, Yang K, Lin J, Jing J, Zhao X, Wang Y
. Association between high-sensitivity C-reactive protein, functional disability, and stroke recurrence in patients with acute ischaemic stroke: A mediation analysis. EBioMedicine. 2022; 80:104054.
PMC: 9118507.
DOI: 10.1016/j.ebiom.2022.104054.
View
18.
Kelly P, Lemmens R, Tsivgoulis G
. Inflammation and Stroke Risk: A New Target for Prevention. Stroke. 2021; 52(8):2697-2706.
DOI: 10.1161/STROKEAHA.121.034388.
View
19.
Akhtar S, Gremse F, Kiessling F, Weber C, Schober A
. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice. Arterioscler Thromb Vasc Biol. 2013; 33(4):679-86.
DOI: 10.1161/ATVBAHA.112.301162.
View
20.
Cagnin S, Biscuola M, Patuzzo C, Trabetti E, Pasquali A, Laveder P
. Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. BMC Genomics. 2009; 10:13.
PMC: 2654039.
DOI: 10.1186/1471-2164-10-13.
View